Editorials

• Radial Artery Access: Should it Be Used More Often?

  Jaime Elízaga Corrales

  Rev Esp Cardiol. 2003;56:124-7

• Role of Anti-Inflammatory Drugs in the Treatment of Acute Coronary Syndromes. From Athero-Inflammation to Athero-Thrombosis

  Raúl Altman, Alejandra Scazziota

  Rev Esp Cardiol. 2003;56:9-15

• The Current State of Hormonal Prevention of Coronary Heart Disease in Menopausal Women

  Nanette K Wenger

  Rev Esp Cardiol. 2003;56:1-8

• Troponins and Other Markers of Cardiac Damage. Miths and Realities

  José López-Sendón

  Rev Esp Cardiol. 2003;56:16-9

• Heart Failure: Old Questions, Insufficient Answers

  Gaietà Permanyer Miralda

  Rev Esp Cardiol. 2003;56:20-2

• Annexin V Levels in Young Patients with Acute Myocardial Infarction: New Answers Bring New Questions

  Julio I Osende Olea

  Rev Esp Cardiol. 2002;55:1223-5

• Clinical Management and Common Sense

  Jesús Gutiérrez Morlote

  Rev Esp Cardiol. 2002;55:1226-9

• Cardiac Surgery in Elderly Patients

  Jesús M Herreros

  Rev Esp Cardiol. 2002;55:1114-6

• Has the Prognosis of Cardiogenic Shock Post Myocardial Infarction Changed?

  Ramón Corbalán

  Rev Esp Cardiol. 2002;55:1111-3

• Non Precordial Leads and the Level of Coronary Obstruction in Acute Anterior Myocardial Infarction: Something Clinically Useful or Only Redundant Information?

  Jaume Figueras

  Rev Esp Cardiol. 2002;55:1015-7

• Secondary Prevention of Coronary Artery Disease. Flu Vaccinations and New Evidence of the Role of Infection in Acute Coronary Syndromes

  Enrique Gurfinkel, Branco Mautner

  Rev Esp Cardiol. 2002;55:1009-12

• Chest Pain Units. A Cardiologist´s Plea for its Urgent Implementation

  Eduardo Alegría Ezquerra, Julián Bayón Fernández

  Rev Esp Cardiol. 2002;55:1013-4

• Do Clinical Trials Tell us All the Truth? Relative Versus Absolute Risks and their Influence on the Therapeutic Decisions of Cardiologists

  Rafael Gabriel Sánchez

  Rev Esp Cardiol. 2002;55:1018-20

• Ventricular Septal Defect with Aortic Regurgitation. An Unsolved Problem

  M Jesús Maître Azcárate

  Rev Esp Cardiol. 2002;55:897-9

• Beyond Blood Pressure Reduction in the Treatment of Arterial Hypertension. Clinical Implications of the LIFE Study

  José R González-Juanatey

  Rev Esp Cardiol. 2002;55:887-94

• Collaborate Either Multi-Disciplinarily, Trans-Disciplinarily, or Inter-Disciplinarily, and Please Advance Together

  Jaume Marrugat

  Rev Esp Cardiol. 2002;55:895-6

• The Registries of Myocardial Infarction: An Opportunity for Improvement. The PREVESE II Study

  Fernando Arós

  Rev Esp Cardiol. 2002;55:791-2

• Infective Endocarditis: Are we Managing our Patients Well?

  Pilar Tornos

  Rev Esp Cardiol. 2002;55:789-90

• Direct Stenting: The Decline of the Balloon?

  Luis Martínez Elbal

  Rev Esp Cardiol. 2002;55:703-4

• Platelet Antiaggregation Treatment in the Aftermath of GUSTO IV, TARGET, TACTICS, and CURE Trials

  Jean-Pierre Bassand

  Rev Esp Cardiol. 2002;55:697-702